Compare Pfizer Inc (PFE) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Roblox Corp — how do they compare? Pfizer Inc trades at $27.82 (market cap $158.34B), while Roblox Corp trades at $45 (market cap $31.80B). The key difference: Pfizer Inc is far larger — about 5× Roblox Corp's market cap, and Pfizer Inc pays a 6.19% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| PFE | RBLX | |
|---|---|---|
Market Cap | $158.34B | $31.80B |
Volume | 29,869,932 | — |
Sector | Health | Media |
52-Week High | $29.02 | $141.56 |
52-Week Low | $23.60 | $35.54 |
Enterprise Value | $209.83B | $30.63B |
Dividend Yield | 6.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.79, down 2.32% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported revenue of $62.58B in 2025 with a net income margin of 12.41%, though earnings are expected to decline in 2026. Recent quarterly EPS beats and a dividend of $0.43 payable in September 2026 provide support, while analyst consensus is a hold with a $28.33 price target.
Outlook: PFE offers value with a forward P/E near sector averages and strong cash flow, but faces headwinds from patent expirations and projected earnings decline. Investment appeal lies in its dividend yield and pipeline catalysts in obesity/oncology, though execution risks and competitive pressures warrant caution for growth-focused investors.
Roblox (RBLX) trades at $44.82, up 3.49% today, with a bullish technical signal and strong revenue growth to $4.89B in 2025, though net losses persist. Recent earnings beats and positive cash flow trends contrast with high valuation ratios and regulatory scrutiny. The stock is near its consensus price target of $45.71, with support at $43 and resistance at $46.
Outlook: Long-term growth potential via user engagement and creator economy is tempered by profitability challenges and child-safety regulations. Risks include sustained losses and competitive pressure, but analyst sentiment leans slightly bullish with 44.74% buy ratings. Investors should weigh revenue momentum against margin improvement needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
